Analysis of the Adverse Event Profiles of Medications for Alcohol Use Disorder: Insights from a Japanese Pharmacovigilance Database
Authors:
- 9 February 2026
- journal article
- research article
- Published by Springer Nature in International Journal of Mental Health and Addiction
- p. 1-16
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- From Medication to Complication: A Case Report of Acute Eosinophilic Pneumonia Associated With NaltrexoneClinical Case Reports, 2025
- Adverse drug event profile of pharmacotherapies for alcohol use disorder: a retrospective pharmacovigilance disproportionality analysis studyExpert Opinion on Drug Safety, 2025
- Pharmacotherapy for Alcohol Use DisorderJAMA, 2023
- Delayed onset of impaired consciousness complicated with ketoacidosis after disulfiram overdoseAcute Medicine & Surgery, 2023
- Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of EvidenceDrug Safety, 2016
- Acamprosate for alcohol dependenceCochrane Database of Systematic Reviews, 2010
- Cyanamide-induced aplastic anemiaEuropean Journal of Clinical Pharmacology, 2005
- Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesvirusesJournal of Medical Virology, 2005
- A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactionsPharmacoepidemiology and Drug Safety, 2002
- Relapsing pancytopenia following exposure and re-exposure to cyanamideEuropean Journal of Haematology, 2000